Research limitations and gaps What we know well Strong evidence : GLP-1 peptides for weight loss Growth hormone peptides elevate GH/IGF-1 Some healing peptides (TB-500 in clinical trials) Mechanism of action for most peptides What needs more research Limited human data : BPC-157: Extensive animal studies, limited human trials Many healing peptides: Great anecdotal evidence, need formal studies Long-term safety (5+ years): Limited data for many research peptides Optimal dosing: Often based on extrapolation from animal studies Why research is limited : Expensive to conduct clinical trials ($millions) No patent protection for most peptides (generic amino acid sequences) Pharmaceutical companies focus on patentable drugs Research peptides exist in regulatory gray area What this means : Some peptides have strong evidence (FDA-approved) Others have good preclinical evidence but limited human trials Anecdotal evidence extensive for many compounds Users serve as "citizen scientists" in some cases How to evaluate peptide research Here are some questions to ask Has it been studied in humans
It is a is a copper complex of glycyl-L-histidyl-lysine and can be naturally found in urine, saliva, and plasma
[DOI] [PubMed] [Google Scholar] 41.Cuneo RC, Salomon F, Wiles CM, Round JM, Jones D, Hesp R, Sonksen PH
Andrew Hub...: So
[33] Biochemistry [edit] It is not totally clear why cells make folinic acid (5fTHF)
Interestingly, mice treated chronically with ethanol for 78 weeks present an altered glucose metabolism and transport in the brain [24]
